% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Meyer:300192,
author = {S. P. Meyer and R. Bauer and B. Brüne and T. Schmid$^*$},
title = {{T}he role of type {I} interferon signaling in myeloid
anti-tumor immunity.},
journal = {Frontiers in immunology},
volume = {16},
issn = {1664-3224},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2025-00669},
pages = {1547466},
year = {2025},
abstract = {Tumors often arise in chronically inflamed, and thus
immunologically highly active niches. While immune cells are
able to recognize and remove transformed cells, tumors
eventually escape the control of the immune system by
shaping their immediate microenvironment. In this context,
macrophages are of major importance, as they initially exert
anti-tumor functions before they adopt a tumor-associated
phenotype that instead inhibits anti-tumor immune responses
and even allows for sustaining a smoldering inflammatory,
growth promoting tumor microenvironment (TME). Type I
interferons (IFNs) are well established modulators of
inflammatory reactions. While they have been shown to
directly inhibit tumor growth, there is accumulating
evidence that they also play an important role in altering
immune cell functions within the TME. In the present review,
we focus on the impact of type I IFNs on anti-tumor
responses, driven by monocytes and macrophages.
Specifically, we will provide an overview of tumor-intrinsic
factors, which impinge on IFN-stimulated gene (ISG)
expression, like the presence of nucleic acids, metabolites,
or hypoxia. We will further summarize the current
understanding of the consequences of altered IFN responses
on macrophage phenotypes, i.e., differentiation,
polarization, and functions. For the latter, we will focus
on macrophage-mediated tumor cell killing and phagocytosis,
as well as on how macrophages affect their environment by
secreting cytokines and directly interacting with immune
cells. Finally, we will discuss how type I IFN responses in
macrophages might affect and should be considered for
current and future tumor therapies.},
subtyp = {Review Article},
keywords = {Humans / Interferon Type I: metabolism / Interferon Type I:
immunology / Neoplasms: immunology / Neoplasms: metabolism /
Tumor Microenvironment: immunology / Signal Transduction /
Animals / Macrophages: immunology / Macrophages: metabolism
/ Myeloid Cells: immunology / Myeloid Cells: metabolism /
hypoxia (Other) / macrophage (Other) / phagocytosis (Other)
/ polarization (Other) / tumor microenvironment (Other) /
type I interferon (Other) / Interferon Type I (NLM
Chemicals)},
cin = {FM01},
ddc = {610},
cid = {I:(DE-He78)FM01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40098954},
pmc = {pmc:PMC11911529},
doi = {10.3389/fimmu.2025.1547466},
url = {https://inrepo02.dkfz.de/record/300192},
}